4//SEC Filing
Kearney Terrence C 4
Accession 0000899243-23-018113
CIK 0000875320other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:09 PM ET
Size
8.5 KB
Accession
0000899243-23-018113
Insider Transaction Report
Form 4
Kearney Terrence C
Director
Transactions
- Exercise/Conversion
Common Stock
2023-08-10$127.54/sh+10,000$1,275,400→ 16,536 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-08-10−10,000→ 10,000 totalExercise: $127.54Exp: 2025-05-31→ Common Stock (10,000 underlying) - Sale
Common Stock
2023-08-10$350.00/sh−10,000$3,500,000→ 6,536 total
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Kearney's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.
- [F2]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001289098
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:09 PM ET
- Size
- 8.5 KB